Patent 7875271 was granted and assigned to Senju Pharmaceutical on January, 2011 by the United States Patent and Trademark Office.
The present invention provides an ophthalmic composition containing xanthan gum and glucose, which has a superior corneal epithelial disorder-treating effect.